Pharmacologic Management of Diabetes to Achieve Optimal Glycemic Control

Access Activity

Overview / Abstract:

This online module will discuss oral and injectable medications to treat diabetes including combination regimens. The learner will consider the American Diabetes Association (ADA) guidelines and the therapeutic experiment as they practice the pharmacotherapeutic management of patients with diabetes and cardiovascular disease (CVD).

Learning Objectives:
At the end of this activity, participants should be able to:

1. State the general approaches to treatment recommended by the American Diabetes Association (ADA) and American Association of Clinical Endocrinologist (AACE);
2. Describe the mechanism of action, advantages, major adverse effects, and relative cost of the following medication classes: Alpha-glucosidase inhibitor, Amylin analogs, Biguanides, Bile acid sequestrants, Dipeptidyl-peptidase-4 (DPP4) inhibitors, Dopamine agonists, Glucagon-like peptide-1 (GLP-1) receptor agonists, Insulin – human and insulin analogs, Meglitinides, Sodium glucose transporter-2 (SGLT2) inhibitors, Sulfonylureas and Thiazolidenediones (TZDs);
3. Explain why metformin is the cornerstone of therapy for type 2 diabetes;
4. Given a brief case vignette, determine what patient-related variables should influence the treatment recommendation and what additional information is needed to make a well-informed decision;
5. Given a brief case vignette, develop a patient monitoring plan including indices of efficacy and toxicity; and
6. Given a brief case vignette, develop a patient education plan.

Universal Activity Number (UAN): 0025-0000-16-057-H01-P


May 01, 2019


Pharmacy CPE


Online, Webinar / Webcast / Video



Credits / Hours

3.5 credit hours



Presenters / Authors / Faculty

Stuart T. Haines, PharmD, BCPS, BACP, BC-ADM, Professor, Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy

Activity Specialities / Related Topics

Diabetes, Diagnosis / Assessment / Patient History

Sponsors / Supporters / Grant Providers

University of Maryland School of Pharmacy, CIPS Knowledge Enterprise

Keywords / Search Terms

University of Maryland School of Pharmacy: CIPS Knowledge Enterprise CIPS, University of Maryland, Diabetes, American Diabetes Association guidelines, cardiovascular disease, CVD, ADA

Access Activity

RXinsider,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps. RXinsider,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the Terms of Service. Site Map.